Saxagliptin and Metformin Hydrochloride
These highlights do not include all the information needed to use SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. SAXAGLIPTIN and METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 2010
65884427-4dde-63bb-a23f-36a7779c0a6b
HUMAN PRESCRIPTION DRUG LABEL
Jul 28, 2023
Dr.Reddys Laboratories Inc
DUNS: 802315887
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Saxagliptin and Metformin Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (20)
Saxagliptin and Metformin Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (21)
Saxagliptin and Metformin Hydrochloride
Product Details
FDA regulatory identification and product classification information